简化临床脆弱性尺度的设计,验证和适应在老年患者
T-V Nguyen1, G-M Tran, T-T-T Nguyen
1Department of Geriatrics, Faculty of Medicine, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam. nhha82@ctump.edu.vn.
European review for medical and pharmacological sciences
|March 18, 2024
概括
简化临床虚弱度表 (sCFS) 准确评估老年患者的虚弱度. 这种新工具与原来的临床虚弱度量表 (CFS) 有很高的相关性和一致性,为内科医生提供了更实用的评估.
科学领域:
- 老年病的医生 老年病的医生
- 临床评估 临床评估
- 健康结果的健康结果.
背景情况:
- 临床虚弱度表 (CFS) 是一种用于评估老年患者的虚弱度的工具,考虑临床检查,并发症和功能状态.
- 内科医生在准确应用CFS时面临挑战,需要简化和有效的脆弱性评估工具来改善患者护理.
- 为了应对这些挑战并促进更好的治疗结果,开发了一种简化的临床脆弱性量表 (sCFS).
研究的目的:
- 设计一个简化的临床虚弱度表 (sCFS) 来评估老年患者的虚弱度.
- 评估新设计的sCFS与已建立的CFS之间的相关性和一致性.
- 为了确定sCFS与CFS相比的诊断准确度.
主要方法:
- 对279名老年患者进行了横截面分析.
- 由老年病专业委员会 (GPC) 认可的简化临床脆弱性量表 (sCFS) 协议已实施.
- 使用sCFS和CFS来评估脆弱性,并进行了比较的统计分析.
主要成果:
- 在sCFS和CFS之间观察到很高的相关性 (皮尔森的r = 0.996,p < 0.001).
- 在两个尺度之间发现了很好的一致性,卡帕系数为0.984 (p < 0.001).
- 与CFS相比,sCFS表现出高的诊断准确性,具有100%的灵敏度和98%的特异性 (尤登指数=98%).
结论:
- 简化临床虚弱度表 (sCFS) 是评估老年人虚弱度的有效和可靠工具.
- sCFS具有很高的灵敏度和特异性,使其成为临床使用中CFS的实际替代品.
- 实施sCFS可以帮助内科医生更有效,更准确地评估脆弱性,从而有可能改善治疗策略.
相关概念视频
01:15Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
861
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
861
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
382
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
382
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
400
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
354
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
354
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367